KIFC1 is a novel potential therapeutic target for breast cancer.
about
KIFC1: a promising chemotherapy target for cancer treatment?Recent findings and future directions for interpolar mitotic kinesin inhibitors in cancer therapyPrecocious centriole disengagement and centrosome fragmentation induced by mitotic delayA centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomasDiscovery of a novel inhibitor of kinesin-like protein KIFC1The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells.Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers.Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer.Discovery of Novel Allosteric Eg5 Inhibitors Through Structure-Based Virtual Screening.Dividing with Extra Centrosomes: A Double Edged Sword for Cancer Cells.miR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1.C-terminal kinesin motor KIFC1 participates in facilitating proper cell division of human seminomaStructural basis of small molecule ATPase inhibition of a human mitotic kinesin motor protein.Evolving Therapeutic Strategies to Exploit Chromosome Instability in Cancer.Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics.Radiation-Induced Gene Expression Changes in High and Low Grade Breast Cancer Cell Types.Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer.KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma.
P2860
Q26751207-387EBBC1-B6E5-4620-A3FD-54F95F4BAAC3Q28076992-538BCFEB-D786-4848-94DB-E2D53048C8CAQ33810216-9800B6A3-F1A8-461E-B7AB-9FEEB9E54FCDQ33816666-45811E5C-0131-403C-9402-F598342A68DDQ33847398-5DE5D6E9-876F-402C-AFA8-9BD2ADE1525DQ35963684-D8550E1D-C6FA-4830-B31E-A078BAE65E03Q36061121-8FBE8CF3-E0DE-46C9-8D45-A5C189022E4DQ37565093-05ECD876-6F96-4013-AFAC-B2E3F5492726Q38795153-A6E8BFF8-23A4-493C-8524-7629FB4B4516Q39363632-C3422057-964F-4EA4-8058-A90D35287400Q40672156-762E9E7F-1C18-40C9-BEF9-987E1309A5D4Q42105455-F0654190-E031-4C76-AF54-5975FC2F0804Q44722786-67AC90BD-038C-466E-B590-0F8A09F39508Q47119995-ACB1CF01-D574-4AB3-B591-14C969331D63Q47616417-A2740FCE-626C-436E-A756-A5A65D062813Q52721717-89C9FEAC-968A-4B72-923F-EC01E81BA44EQ52726773-8F3D9054-E7FC-4B6B-9218-09EBECE6C7D4Q54117518-6E7C79F3-43E7-4D6C-AD29-1599449657A9
P2860
KIFC1 is a novel potential therapeutic target for breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
KIFC1 is a novel potential therapeutic target for breast cancer.
@ast
KIFC1 is a novel potential therapeutic target for breast cancer.
@en
type
label
KIFC1 is a novel potential therapeutic target for breast cancer.
@ast
KIFC1 is a novel potential therapeutic target for breast cancer.
@en
prefLabel
KIFC1 is a novel potential therapeutic target for breast cancer.
@ast
KIFC1 is a novel potential therapeutic target for breast cancer.
@en
P2093
P2860
P1476
KIFC1 is a novel potential therapeutic target for breast cancer
@en
P2093
Dongquan Chen
Indira Padmalayam
Rebecca J Boohaker
P2860
P304
P356
10.1080/15384047.2015.1070980
P577
2015-07-15T00:00:00Z